Physician communication regarding cost when prescribing asthma medication to children.
Physician communication regarding cost when prescribing asthma medication to children.
复制标题
医生在向儿童开哮喘药物时就费用进行沟通。
DOI：
10.1177/0009922808330110
复制
发表时间：
2009
影响因子：
1.6
通讯作者：
Cabana,MichaelD
中科院分区：
文献类型：
--
作者：
Patel,MinalR;Coffman,JanetM;Tseng,Chien-Wen;Clark,NoreenM;Cabana,MichaelD
患有哮喘的儿童需要多种药物，费用可能是治疗的障碍。本研究的目的是确定医生在开新的哮喘药物时询问费用的频率，并确定影响询问的因素。我们调查了儿科医生和家庭医生，询问他们在开新的哮喘药物时是否会询问费用，以及费用是否是开处方的障碍。三分之一的医生（35%）报告说，对家庭成本的担忧是开处方的障碍。一半的人报告说他们没有问过病人关于药物费用的问题。与家庭医生相比，儿科医生不太可能询问费用（比值比[OR] = 0.43; 95%置信区间[CI] = 0.20-0.92）。私人保险患者的数量每增加10%，医生就不太可能询问费用（OR = 0.83; 95%CI = 0.74-0.94）。关于药物费用的沟通应包括在儿童哮喘管理中。
Children with asthma require multiple medications, and cost may be a barrier to care. The purpose of this study was to determine how often physicians ask about cost when prescribing new asthma medication and to identify factors influencing queries. We surveyed pediatricians and family physicians and asked whether they asked about cost when prescribing new asthma medication and if cost was a barrier to prescribing. One third of physicians (35%) reported that concern for cost to the family was a barrier to prescribing. Half reported not asking their patients about drug costs. Pediatricians were less likely to ask about cost (odds ratio [OR] = 0.43; 95% confidence interval [CI] = 0.20-0.92) when compared with family physicians. For every 10% increase in the number of privately insured patients, a physician was less likely to ask about cost (OR = 0.83; 95% CI = 0.74-0.94). Communication about medication costs should be included in childhood asthma management.